Two recent reports by the Health Care Cost Institute appear to use an oversimplified analytic approach and draw overly broad conclusions about price variation and price growth variation, writes Aaron Wesolowski, AHA’s vice president for policy research, analytics and strategy. He says their analysis does not address many of the key factors that can contribute to price variation and growth, while ignoring broader trends in the health care market. Read more

Related News Articles

News
The Food and Drug Administration today revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab,…
Headline
The House of Representatives today passed by a vote of 254-166 the Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 1195).…
Headline
Reps. Cheri Bustos, D-Ill., Tom Cole, R-Okla., Jim McGovern, D-Mass., and Markwayne Mullin, R-Okla., today reintroduced the Social Determinants Accelerator Act…
Headline
The House of Representatives last night voted 384-38 to pass a bill that, among other health care provisions, would eliminate the 2% across-the-board cut…
Headline
Fourteen organizations, including the AHA, yesterday urged the Department of Health and Human Services to extend the Next Generation Accountable Care…
Headline
Reps. Terri Sewell, D-Ala., and Vern Buchanan, R-Fla., today introduced The Resetting the Impact Act (TRIA) of 2021, AHA-supported legislation that takes…